The survey data shows that the sales value of Moxifloxacin has grown steadily from 2016 to 2019 in China. In 2020, the sales value of Moxifloxacin fell by 41.23% in China, from CNY1.882 billion in 2019 to CNY1.106 billion in 2020. Due to the second batch of state-organized centralized procurement of medicines, and manufacturers of Moxifloxacin compete by reducing prices. Moxifloxacin of Bayer Vital GmbH dropped by 77.70%, and Moxifloxacin of Nanjing Youke Pharmaceutical Co., Ltd. dropped by 53.07%. The CAGR of the sales value of Moxifloxacin in 2016-2020 is -3.76% in China.
The analyst predicts that with the effective relief of the COVID-19 epidemic, the sales of Moxifloxacin in the Chinese market will have a recovery growth in 2021-2025. In addition, there are 19 pharmaceutical companies that have entered the Chinese Moxifloxacin market by 2020. It is expected that the price of Moxifloxacin will decline with the addition of new manufacturers, and there is room for growth in sales volume and sales. At the same time, compared with similar drugs, Moxifloxacin has a broad antibacterial spectrum, strong curative effect and other advantages, so the sales volume of Moxifloxacin in China will maintain a growth trend.
Topics Covered:
- The impact of COVID-19 on China's Moxifloxacin market
- Sales value of China's Moxifloxacin 2016-2020
- Competitive landscape of China's Moxifloxacin market
- Prices of Moxifloxacin in China
- Prices of Moxifloxacin in China by regions and manufacturers
- Analysis of factors affecting the development of China's Moxifloxacin market
- Prospect of China's Moxifloxacin market from 2021 to 2025
Table of Contents
1.1 Indications for Moxifloxacin1.2 Development of Moxifloxacin in China
1.3 Governmental Approval of Moxifloxacin in China
1.4 The Impact of COVID-19 on Moxifloxacin sales in China
Samples
LOADING...
Companies Mentioned
- Bayer Vital GmbH
- Nanjing Yoko Pharmaceutical Group Co., Ltd.
- Chengdu Tiantaishan Pharmaceutical Co., Ltd.
- Chengdu Zhengkang Pharmaceutical Co., LTD.
- Jiangsu Zhengda Fenghai Pharmaceutical Co. Ltd
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...
Table Information
Report Attribute | Details |
---|---|
Published | June 2021 |
Forecast Period | 2016 - 2025 |
Estimated Market Value ( CNY | CNY 1289.34 Million |
Forecasted Market Value ( CNY | CNY 1949.17 Million |
Compound Annual Growth Rate | 4.7% |
Regions Covered | China |
No. of Companies Mentioned | 5 |